Emerald Advisers’s Wave Life Sciences WVE Stock Holding History

Emerald Advisers’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.11M	Sell	1,223,965 -37,218	-3%	-$247K	0.17%	115
2026 Q1	$9.14M	Sell	1,261,183 -1,193,906	-49%	-$15.6M	0.29%	104
2025 Q4	$41.7M	Sell	2,455,089 -541,811	-18%	-$5.51M	1.29%	18
2025 Q3	$21.9M	Sell	2,996,900 -260,219	-8%	-$2.11M	0.7%	60
2025 Q2	$21.2M	Buy	3,257,119 +123,561	+4%	+$816K	0.78%	48
2025 Q1	$25.3M	Sell	3,133,558 -28,811	-0.9%	-$315K	1.14%	33
2024 Q4	$39.1M	Buy	3,162,369 +280,859	+10%	+$3.75M	1.52%	12
2024 Q3	$23.6M	Buy	2,881,510 +388,280	+16%	+$2.32M	0.91%	46
2024 Q2	$12.4M	Buy	+2,493,230	New	+$14.2M	0.52%	69

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Emerald Advisers's WVE Position: Q2 2026 in Review

Emerald Advisers reduced its Wave Life Sciences (WVE) stake by 3% in Q2 2026, selling an estimated $247K and leaving 1,223,965 shares worth $7.11M. The position accounts for 0.17% of the portfolio, ranked #115.

Emerald Advisers first reported a position in WVE in Q2 2024 and has held it in 9 quarters since. The position peaked at $41.7M in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Emerald Advisers held 1,223,965 shares of Wave Life Sciences worth $7.11M as of Q2 2026.
Emerald Advisers sold 37,218 Wave Life Sciences shares in Q2 2026, an estimated $247K.
Wave Life Sciences made up 0.17% of Emerald Advisers's portfolio in Q2 2026, its #115 holding.
Emerald Advisers first reported a position in Wave Life Sciences in Q2 2024 and has held it in 9 quarters since.
Emerald Advisers's Wave Life Sciences position peaked at $41.7M in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.